ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Vanderbilt Wins Lung Cancer SPORE Grant.

May 18, 2001

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

Radiologists Dispute Holland On NMR

April 20, 1984

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

NCI Plans Network for Providing Access To Pathology Information Over The Web

November 12, 1999